


Semax
<p> Semax is a synthetic nootropic peptide commonly researched for cognitive signalling pathways, neuroprotective models, memory-associated peptide investigations, and neurological research applications under controlled laboratory conditions. </p> <p> Research involving Semax has explored BDNF modulation, neurotransmitter signalling pathways, neuroplasticity models, stress-response regulation, cognitive performance investigations, and peptide-mediated neurological support mechanisms. </p> <p> Semax peptide research is frequently associated with focus and cognition studies, neuroprotection investigations, memory pathway research, peptide-based neurological models, and advanced nootropic peptide applications. </p> <p> This Vital Edge Science batch features Janoshik-verified Semax with a reported purity of 99.562% and independently verified analytical testing. </p> <p> Recommended for reconstitution using bacteriostatic water within controlled laboratory preparation environments. </p> <p> Each vial contains 10mg of high-purity lyophilised Semax intended strictly for analytical, laboratory, and scientific research applications. </p> <p> <strong>For research use only. Not for human consumption.</strong> </p>
Available variants
Product description
Product Overview
Semax is a synthetic nootropic peptide supplied by Vital Edge Science for laboratory research involving cognitive signalling, neuroprotection, memory pathways, neuroplasticity, and advanced neurological investigations. This batch features independent Janoshik verification and Australia/New Zealand fulfilment support.
Available Formats
- 10mg × 1 vial
- 10mg × 10 vials
- MOQ: 1 vial
- Australia / New Zealand fulfilment
Batch Verification
- Purity: 99.562%
- Tested: 13 FEB 2026
- Task Number: #104984
- Verification Key: HDTTL16QC1BE
Research Applications
- Cognitive signalling research
- Neuroprotection investigations
- Memory pathway studies
- BDNF and neuroplasticity research
- Neurological performance models
Verification report

